Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Urine Metabolites in the Diagnosis of Disease

NCT06710067 is registered in ClinicalTrials.gov with Luventix, Inc. as lead sponsor.

NCT NCT06710067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06710067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Urine Metabolites in the Diagnosis of Disease
Lead sponsor
Luventix, Inc.
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2024
Completion date
September 30, 2026
Enrollment
1,250 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease, colorectal cancer, crohn disease, small intestinal bacterial overgrowth syndrome (sibo)